Get informed when a big investor buys or sells
+ Follow369.21%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
T2 Biosystems (TTOO) currently reports a ROE of 369.21%. That is above the Industrials sector average of 35.64%. Use the charts on this page to explore T2 Biosystems's ROE history and peer comparisons.
T2 Biosystems's ROE of 369.21% is higher than the Industrials sector average of 35.64%. That is roughly 936.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but T2 Biosystems's current 369.21% should be judged against Industrials norms (sector average: 35.64%) and against TTOO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 369.21%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is 35.64%. From there, open related valuation or income-statement pages for T2 Biosystems, and consider following TTOO for alerts when major investors trade the stock.
T2 Biosystems is classified in the Industrials sector. On ROE, it currently shows 369.21% versus a sector average near 35.64%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing TTOO with unrelated industries.